German Science & Technology Today
SEE OTHER BRANDS

Your best source on science and technology news from Germany

German Science & Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Science & Technology Today.

Press releases published on May 28, 2025

VSRVES01 - Linux-Capable RISC-V/VSDSP6 System-on-a-Chip

VSRVES01 - Linux-Capable RISC-V/VSDSP6 System-on-a-Chip

VLSI Solution announces VSRVES01, first prototype for an all-new 32-bit RISC-V and VSDSP6 hybrid SoC family, intended for Internet audio and IoT applications. TAMPERE, PIRKANMAA, FINLAND, May 28, 2025 /⁨EINPresswire.com⁩/ -- VLSI Solution announces …

LodgIQ and Medialog Meet Growing Demand for Integrated Hotel Tech in France

LodgIQ and Medialog Meet Growing Demand for Integrated Hotel Tech in France

AI-powered revenue management and seamless PMS connectivity aim to deliver a unified revenue management and BI solutions for French hoteliers SUNNYVALE, CA, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- LodgIQ, the AI-powered revenue management …

Titan OS to announce the availability of TimVision on Titan OS-powered smart TVs across Italy

Titan OS to announce the availability of TimVision on Titan OS-powered smart TVs across Italy

Titan OS to announce the availability of TimVision, the premium Italian streaming entertainment service, on Titan OS-powered smart TVs across Italy. BARCELONA, BARCELONA, SPAIN, May 28, 2025 /⁨EINPresswire.com⁩/ -- — Titan OS S.L. (Titan OS), the …

Vidac Pharma Reports Exceptional Pharmacokinetics of  Almavid™ Drug Candidate in Real-World Clinical study

Vidac Pharma Reports Exceptional Pharmacokinetics of Almavid™ Drug Candidate in Real-World Clinical study

Revolutionary cancer treatment demonstrates potential for Almavid™ Drug Candidate application in solid tumors. Vidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- Vidac …

DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa

DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa

Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa. Dermaliq’s proprietary hyliQ® technology platform enables …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service